Enrico D, Gomez JE, Aguirre D, Tissera NS, et al. Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM). Clin Lung Cancer 2024;25:723-731.
PMID: 39424512